Literature DB >> 2668274

Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase.

E U Lee1, J Roth, J C Paulson.   

Abstract

In this report we describe the alteration of the N-linked oligosaccharide terminal sequences of Chinese hamster ovary cell glycoproteins by expression of a beta-galactoside alpha 2,6-sialyltransferase cDNA. While wild type cells normally produce sugar chains terminating in the NeuAc alpha 2,3Gal linkage, the expressed enzyme competes with the endogenous sialyltransferase to attach an alternative terminal sequence, NeuAc alpha 2,6Gal. Subcellular localization of the NeuAc alpha 2,6Gal product by lectin-gold electron microscopy revealed localization throughout the Golgi apparatus cis to trans, post-Golgi membranes and vesicular structures. The results demonstrate the potential for purposefully altering terminal carbohydrate structures in vivo by "mis-expressing" terminal glycosyltransferases that compete with the endogenous enzyme normally produced by the cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668274

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Overexpression of alpha2,3 sialyltransferase in neuroblastoma cells results in an upset in the glycosylation process.

Authors:  N Georgopoulou; K C Breen
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

2.  Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Authors:  L Monaco; A Marc; A Eon-Duval; G Acerbis; G Distefano; D Lamotte; J M Engasser; M Soria; N Jenkins
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 3.  Mammalian glycosylation mutants as tools for the analysis and reconstitution of protein transport.

Authors:  A W Brändli
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  High-throughput N-glycan screening method for therapeutic antibodies using a microchip-based DNA analyzer: a promising methodology for monitoring monoclonal antibody N-glycosylation.

Authors:  Mitsuhiro Kinoshita; Kazuki Nakajima; Sachio Yamamoto; Shigeo Suzuki
Journal:  Anal Bioanal Chem       Date:  2021-06-02       Impact factor: 4.142

5.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.

Authors:  B J Bast; L J Zhou; G J Freeman; K J Colley; T J Ernst; J M Munro; T F Tedder
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

6.  DS28-6, a temperature-sensitive mutant of Chinese hamster ovary cells, expresses key phenotypic changes associated with brefeldin A treatment.

Authors:  C Zuber; J Roth; T Misteli; A Nakano; K Moremen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

7.  Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.

Authors:  Nan Lin; Joaquina Mascarenhas; Natalie R Sealover; Henry J George; Jeanne Brooks; Kevin J Kayser; Brian Gau; Isil Yasa; Parastoo Azadi; Stephanie Archer-Hartmann
Journal:  Biotechnol Prog       Date:  2015-03-01

8.  Efficient amplification using 'megaprimer' by asymmetric polymerase chain reaction.

Authors:  A K Datta
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

9.  The expression of neural cell sialoglycoproteins following glucocorticoid regulation of sialyltransferase activity in vivo.

Authors:  C M Coughlan; J R Seckl; K C Breen
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

10.  N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells.

Authors:  Kyung Jin Lee; Sang Mee Lee; Jin Young Gil; Ohsuk Kwon; Jin Young Kim; Soon Jae Park; Hye-Shin Chung; Doo-Byoung Oh
Journal:  Glycoconj J       Date:  2012-10-12       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.